Ann: Study 6 Successfully Concluded - Exceptional Results, page-7

Exceptional result indeed! Sensitivity increased from 77% to 84%. RHY ColoSTAT test-kits would meet requirements for reimbursement eligibility in the US based on 84% sensitivity and 94% specificity. Noting US is a huge market.

Study 6 objectives have been met - demonstrated the analytical performance of the test-kits manufactured by third party and has exceed previous results (based on 300 blood samples). Opportunity to further improve results for Study 7 with continuous improvements of RHY’s proprietary algorithms read using machine intelligence (AI)